Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 5,301–5,325 of 27,380 studies, newest first · page 213 of 1096.

February 2025 25

  1. 2025-02-06

    Perspectives on Diet and Exercise Interaction for Healthy Aging: Opportunities to Reduce Malnutrition Risk and Optimize Fitness

    ✓ Peer-reviewed Prevention and risk Nutrients

    Key finding: Additionally, supplementation strategies, such as omega-3 fatty acids, creatine, and essential amino acids, are explored alongside the emerging role of the gut microbiota in mediating the benefits of nutrition and exercise. +4 more findings

  2. 2025-02-06

    A Roadmap for Disaster Risk Reduction and Management in Kidney Care

    ✓ Peer-reviewed Prevention and risk Journal of the American Society of Nephrology

    Key finding: Key Points Disasters cause significant human suffering, and patients with kidney diseases are uniquely vulnerable. +3 more findings

  3. 2025-02-06

    Is Australia ready for the rollout of amyloid‐targeting therapies for Alzheimer disease? Results from a national survey characterising current infrastructure capability, workforce and training needs of memory and cognition clinics

    ✓ Peer-reviewed Treatments Internal Medicine Journal

    Key finding: Thirty medical specialists (geriatricians, n = 23; psychiatrists, n = 4; neurologists, n = 3) from 30 different clinics participated (public, 76.7%; private, 23.3%), including from metropolitan (73.3%), regional (20.0%) and rural (6.7%) areas. +4 more findings

  4. 2025-02-06

    Cost-Effectiveness of a Digitally Supported Care Management Program for Caregivers of People With Dementia

    ✓ Peer-reviewed Costs and economics Value in Health

    Key finding: CMS was likely cost-effective from the payer but not from a societal perspective, underlining the importance of informal care. +2 more findings

  5. 2025-02-05
  6. 2025-02-05

    Amyloid-β can activate JNK signalling via WNT5A-ROR2 to reduce synapse formation in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Journal of cell science

    Key finding: In induced pluripotent stem cell (iPSC)-derived cortical neurons carrying a PSEN1 mutation, known to increase the Aβ42/40 ratio, we observed increased WNT5A-ROR2 clustering and reduced numbers of synapses. +1 more finding

  7. 2025-02-05

    Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: NfL demonstrated fair to excellent accuracy in differentiating non-ACS from CU groups (area under the curve [AUC], 0.79 to 0.94). p-tau217 had the highest accuracy for identifying Aβ (AUC 0.94) and tau positron emission tomography status (AUC 0.91). +4 more findings

  8. 2025-02-05

    Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer's Disease

    ✓ Peer-reviewed Treatments Clinical pharmacokinetics

    Key finding: The steady-state plasma PK results were closely aligned with the previous 2-week PK in the ALZ-801 phase 1b study in APOE4 carrier subjects with AD, as well as a phase 1 7-day PK study in heathy elderly volunteers. +4 more findings

  9. 2025-02-05

    The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Plasma p-tau217 showed larger fold-changes and better accuracy for detecting AD pathology in symptomatic individuals, with greater cross-platform agreement than other p-tau variants. +1 more finding

  10. 2025-02-05

    “By the Time We Knew …”: Poetic Analysis of End‐of‐Life Caregiving Experiences for Rapidly Progressive and Slower‐Duration Dementia Syndromes

    ✓ Peer-reviewed End-of-life care Journal of the American Geriatrics Society

    Key finding: "Rapid-type" caregivers (n = 12) had a median age of 59 (range 45-73) years; 6 were female, and 9 were spouses. +4 more findings

  11. 2025-02-05

    Role of visual function and performance of activities of daily living in cognitive function in patients with mild cognitive impairment: a cross-sectional study

    ✓ Peer-reviewed Mild cognitive impairment Frontiers in Aging Neuroscience

    Key finding: These findings suggest that visual function plays a crucial role in the cognitive and functional abilities of patients with MCI. +1 more finding

  12. 2025-02-05
  13. 2025-02-05

    Identifying natural inhibitors against FUS protein in dementia through machine learning, molecular docking, and dynamics simulation

    ✓ Peer-reviewed Digital health tools Frontiers in Neuroinformatics

    Key finding: With a reliable model in hand, our study utilized machine learning techniques, particularly the Random Forest algorithm, to navigate through a vast dataset of phytochemicals. +4 more findings

  14. 2025-02-05

    Informal caregivers’ perspectives on participation in a dementia rehabilitation programme

    ✓ Peer-reviewed Caregiving Scandinavian Journal of Occupational Therapy

    Key finding: There is limited experience in combining interdisciplinary rehabilitation for persons with dementia and caregiver support.

  15. 2025-02-05

    Spatio-temporal modelling of extreme low birth rates in U.S. counties

    ✓ Peer-reviewed Risk factors BMC Public Health

    Key finding: The findings show that elderly, highly educated population structure, city-developed situation, average birth weight, and average age of mother have a significant impact on the stressful downward excess of birth rate, particularly in examples of Charlotte, Sarasota, Collier counties in Florida, and Marin, Santa, Cruuz, San Mateo in California.

  16. 2025-02-04

    Clinical trials targeting tau should be halted

    ✓ Peer-reviewed Drug development Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

    Key finding: Experimental drugs lowering brain tau are heralded as improvements in the treatment of Alzheimer's disease. +3 more findings

  17. 2025-02-04
  18. 2025-02-04
  19. 2025-02-04

    The landscape of autosomal-dominant Alzheimer’s disease: global distribution and age of onset

    ✓ Peer-reviewed Risk genes beyond APOE Brain

    Key finding: We present a comprehensive global analysis of genetic variants associated with autosomal-dominant Alzheimer's disease (ADAD). +1 more finding

  20. 2025-02-04

    Informed consent in dementia research: how Public Involvement can contribute to addressing “old” and “new” challenges

    ✓ Peer-reviewed Digital health tools Frontiers in Dementia

    Key finding: This paper provides an overview of the perspectives of people with dementia and their carers resulting from Public Involvement activities organized by Alzheimer Europe. +4 more findings

  21. 2025-02-04

    Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases

    ✓ Peer-reviewed Prevention and risk International Journal of Molecular Sciences

    Key finding: Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), which are a consequence of the progressive loss of neuronal function and structure, cause significant cognitive impairment. +2 more findings

  22. 2025-02-03

    Which plasma pTau217 assay should I use in clinical practice? Pandora's box demystified

    ✓ Peer-reviewed Biomarkers Brain : a journal of neurology

    Key finding: This scientific commentary refers to ‘A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests’ by Warmenhoven et al. +1 more finding

  23. 2025-02-03

    Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison

    ✓ Peer-reviewed Biomarkers Brain : a journal of neurology

    Key finding: The p-tau217 levels measured by the two techniques demonstrated a strong correlation, showing a consistent relationship with CSF p-tau181 levels. +2 more findings

  24. 2025-02-03

    Longitudinal Cognitive Changes in Cerebral Small Vessel Disease

    ✓ Peer-reviewed Vascular contributions Neurology

    Key finding: One hundred ninety-eight of 229 participants had WMH volumes available at both time-points. +4 more findings

  25. 2025-02-03

    Aligning Medications With What Matters Most: Conversations Between Pharmacists, People With Dementia, and Care Partners

    ✓ Peer-reviewed Disparities Journal of the American Geriatrics Society

    Key finding: The mean (SD) age of PWD was 81 (8.1) years; 45% were women, 33% Black, and 15% Hispanic. +4 more findings

Browse the library by subject, with the full score breakdown →